Dr Kieran Murphy New SpinaFX Medical Chief Medical Officer

Dr. Kieran Murphy has been a pioneer in the field of intradiscal ozone for the treatment of herniated lumbar discs since 2004,” said SpinaFX Medical CEO Jeff Cambra. “We look forward to drawing on Dr. Murphy’s expertise and leadership in the field as we develop minimally-invasive, image guided solutions designed to address the unmet needs of patients, physicians and health systems.”

A leading interventional neuroradiologist, Dr. Murphy brings extensive experience to the role, including training at the Royal College of Surgeons in Ireland, residency and fellowship at Albany Medical Center NY, and the University of Michigan. While in his interventional neuroradiology fellowship at University of Geneva in 1996, he became one of the first physicians to perform vertebroplasty. From 1998 to 2008, he was Director of Interventional Neuroradiology at Johns Hopkins University. He is now Professor of Interventional Neuroradiology and researcher at the University Health Network (UHN) in Toronto, the largest academic center in Canada and ranked as the 4thbest hospital in the world by Newsweek. He treats over 300 patients a year at Toronto Western Hospital.

In addition to his clinical and investigatory work at UHN, Dr. Murphy is a prolific inventor who holds 72 patents, particularly in the areas of spine intervention, vertebroplasty and ozone technology. His vertebroplasty devices are used in over 4,500 hospitals worldwide. He has also created and led medical education programs in Ireland, the United States, the Middle East and elsewhere.

Dr Kieran Murphy is the author of 178 peer-reviewed articles (over 6,500 citations) and the co-author and editor of the bestselling textbook Image-Guided Interventions, published by Elsevier. He is a Fellow of the Society of Interventional Radiology and a senior member of ASSR and ASNR. He is an advisor to TVM Capital, Shore Capital and Generation Capital. He also works closely with the Royal College of Surgeons in Ireland in their global surgery training program.

“I’m thrilled to be part of this exciting venture representing a new frontier in the treatment of herniated discs,” said Murphy. “I have worked hard to understand the mechanism of action of ozone on the nucleus pulposus, to build robust devices, and to study the patient benefit in well-structured clinical trials. I believe that SpinaFX will bring effective minimally invasive technologies to market that have the potential to relieve the suffering of millions of patients with symptomatic herniated lumbar discs around the world.”

“Dr Kieran Murphy is on the leading edge of research in intradiscal ozone for the treatment of herniated discs, and he is a tremendous asset to our team,” said SpinaFX Executive Chair Igor Keselman. “We look forward to driving innovation in the industry together.”

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Jennifer Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in various technical and leadership roles, most recently serving as the Senior Director, Business and Technical Operations.
Chistine Senn will serve as Chair of the Site-Sponsor Consortium – a collaborative body now in its second year – and as Chair of Advarra's Customer Advisory Board. She will also drive and oversee the development of innovative ways to bring clinical trial sites and sponsors together in support of Advarra's mission.
Christopher Slachta joins Cytovale after serving 12 years at Abbott, most recently as divisional vice president of global operations and supply chain, molecular diagnostics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy